Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury.
Model: Moderate controlled cortical impact traumatic brain injury: 4 mm craniectomy over right somatosensory cortex, impact at 3.5 m/s to 1 mm depth with a 2 mm piston and 0.5 s dwell time
Targeted anti-ICAM-1/catalase given 30 min post-impact normalised cortical hydrogen peroxide, cut 3-nitrotyrosine, preserved blood-brain barrier integrity and tight junction proteins, and reduced neuronal loss, astrogliosis and microglial activation. Non-targeted catalase or anti-ICAM-1 antibody al…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.